Literature DB >> 18954742

Marginal zone lymphomas.

Emanuele Zucca1, Francesco Bertoni, Anastasios Stathis, Franco Cavalli.   

Abstract

In the World Health Organization classification of tumors of hematopoietic and lymphoid tissues, the group of marginal zone lymphomas comprises three different entities, namely the extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, the nodal marginal zone B-cell, and the splenic marginal zone B-cell lymphoma (with or without circulating villous lymphocytes). This article addresses each of the marginal zone lymphomas.

Entities:  

Mesh：

Year:  2008        PMID： 18954742     DOI： 10.1016/j.hoc.2008.07.011

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  11 in total

1.  Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

Authors:  Charles C Chu; Lu Zhang; Arjun Dhayalan; Briana M Agagnina; Amanda R Magli; Gia Fraher; Sebastien Didier; Linda P Johnson; William J Kennedy; Rajendra N Damle; Xiao-Jie Yan; Piers E M Patten; Saul Teichberg; Prasad Koduru; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  Ulcerative gastritis secondary to Epstein-Barr viral infection.

Authors:  Adam D Toll; Sajjad Malik; Madalina Tuluc
Journal:  Dig Dis Sci       Date:  2009-01-22       Impact factor: 3.199

3.  Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.

Authors:  Rajko Milosevic; Milena Todorovic; Bela Balint; Miodrag Jevtic; Miodrag Krstic; Elizabeta Ristanovic; Nebojsa Antonijevic; Mirjana Pavlovic; Maja Perunicic; Milan Petrovic; Biljana Mihaljevic
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

Review 4.  Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.

Authors:  Shaun Rosebeck; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Future Oncol       Date:  2011-05       Impact factor: 3.404

5.  The occurrence of sarcoidosis after treatment of nodal marginal B-cell zone lymphoma in a 56-year-old male: A case report from Syria.

Authors:  Aya Soufi; Abeer Abo Nokta; Zuheir Alshehabi; Firas Alhussein
Journal:  Ann Med Surg (Lond)       Date:  2022-07-09

Review 6.  Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.

Authors:  Sung Yong Oh; Cheolwon Suh
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

7.  Primary extranodal marginal zone lymphoma - Epididymis.

Authors:  Shanmugasundaram Rajaian; Marie Therese Manipadam; Sheila Nair; Nitin S Kekre
Journal:  Indian J Urol       Date:  2011-10

Review 8.  Primary spinal mucosa-associated lymphoid tissue lymphoma: A case report.

Authors:  Rongrong Dong; Jiali Ji; Hong Liu; Jue Wang; Xuexin He
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

9.  Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma.

Authors:  Prajwal Dhakal; Vijaya Raj Bhatt; Smrity Upadhyay; Nabin Khanal; Apar Kishor Ganti
Journal:  World J Oncol       Date:  2014-08-25

10.  A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma.

Authors:  Nizar N Abdel-Samad; Judit S Kokai
Journal:  Am J Case Rep       Date:  2019-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.